TY - JOUR
T1 - Non-cell-autonomous tumor suppression by p53
AU - Lujambio, Amaia
AU - Akkari, Leila
AU - Simon, Janelle
AU - Grace, Danielle
AU - Tschaharganeh, Darjus F.
AU - Bolden, Jessica E.
AU - Zhao, Zhen
AU - Thapar, Vishal
AU - Joyce, Johanna A.
AU - Krizhanovsky, Valery
AU - Lowe, Scott W.
N1 - Funding Information:
We gratefully thank Jacqueline Cappellani and Sha Tian for excellent technical assistance; Prem Premsrirut for generating the TG-p53.1224 mouse strain; Orit Pappo for advice in pathological analyses; Vadim Pinskiy and Anna Chuprin for scanning the slides; Carolyn Zawislak for help with NK cell isolation; Anna Sabarovsky for assistance with ultrasound imaging; and Eusebio Manchado, Geulah Livshits, Shane Mayack, and Charles Sherr for constructive criticisms and careful editing of the manuscript. We also thank members of the Lowe laboratory for stimulating discussions. We thank CSHL and MSKCC animal facilities, CSHL histology facility, MSKCC Molecular Cytology Core, and MSKCC Genomics Core. A.L. is funded by EMBO-Long-Term Fellowship; J.A.J. and L.A. are funded by NCI U54 CA148967; D.F.T. is funded by the German Research Foundation (DFG); and V.K. is an incumbent of The Karl and Frances Korn Career Development Chair at Weizmann Institute of Science and is supported by Israel Science Foundation. S.W.L. is the Geoffrey Beene chair for Cancer Biology and is a Howard Hughes Medical Institute investigator. This work was supported by AG16379 grant from the NIA.
PY - 2013/4/11
Y1 - 2013/4/11
N2 - The p53 tumor suppressor can restrict malignant transformation by triggering cell-autonomous programs of cell-cycle arrest or apoptosis. p53 also promotes cellular senescence, a tumor-suppressive program that involves stable cell-cycle arrest and secretion of factors that modify the tissue microenvironment. In the presence of chronic liver damage, we show that ablation of a p53-dependent senescence program in hepatic stellate cells increases liver fibrosis and cirrhosis associated with reduced survival and enhances the transformation of adjacent epithelial cells into hepatocellular carcinoma. p53-expressing senescent stellate cells release factors that skew macrophage polarization toward a tumor-inhibiting M1-state capable of attacking senescent cells in culture, whereas proliferating p53-deficient stellate cells secrete factors that stimulate polarization of macrophages into a tumor-promoting M2-state and enhance the proliferation of premalignant cells. Hence, p53 can act non-cell autonomously to suppress tumorigenesis by promoting an antitumor microenvironment, in part, through secreted factors that modulate macrophage function.
AB - The p53 tumor suppressor can restrict malignant transformation by triggering cell-autonomous programs of cell-cycle arrest or apoptosis. p53 also promotes cellular senescence, a tumor-suppressive program that involves stable cell-cycle arrest and secretion of factors that modify the tissue microenvironment. In the presence of chronic liver damage, we show that ablation of a p53-dependent senescence program in hepatic stellate cells increases liver fibrosis and cirrhosis associated with reduced survival and enhances the transformation of adjacent epithelial cells into hepatocellular carcinoma. p53-expressing senescent stellate cells release factors that skew macrophage polarization toward a tumor-inhibiting M1-state capable of attacking senescent cells in culture, whereas proliferating p53-deficient stellate cells secrete factors that stimulate polarization of macrophages into a tumor-promoting M2-state and enhance the proliferation of premalignant cells. Hence, p53 can act non-cell autonomously to suppress tumorigenesis by promoting an antitumor microenvironment, in part, through secreted factors that modulate macrophage function.
UR - http://www.scopus.com/inward/record.url?scp=84876291823&partnerID=8YFLogxK
U2 - 10.1016/j.cell.2013.03.020
DO - 10.1016/j.cell.2013.03.020
M3 - Article
C2 - 23562644
AN - SCOPUS:84876291823
SN - 0092-8674
VL - 153
SP - 449
EP - 460
JO - Cell
JF - Cell
IS - 2
ER -